Pharmaceutical giant on board

How Graz is becoming a center of cancer research

Samples are analyzed in CBmed's high-tech laboratories in order to gather knowledge for new anti-cancer drugs.(Bild: Foto Fischer,Graz)

Millions invested in the fight against insidious diseases: The German pharmaceutical giant Boehringer Ingelheim is relying on the expertise of a research center in Graz to develop new cancer drugs. 

In strictly shielded laboratories on the campus of the Medical University of Graz, top scientists are using state-of-the-art equipment to research what could save the lives of many cancer patients in the near future: The Styrian research center CBmed has succeeded in starting a cooperation with the German pharmaceutical company Boehringer Ingelheim. Since its foundation ten years ago, CBmed has been building bridges between science and the practical application of research results on patients.